Skip to main content
. 2023 Oct 2;46(11):1161–1172. doi: 10.1007/s40264-023-01348-7

Table 1.

Descriptive statistics of included patients

Patients with ≥ 1 complete ADE reports (N = 2730) Patients with ≥ 1 serious ADE reportsa (N = 1590)
Reports/patient, n (%)
 1 report 2379 (87.1) 1417 (89.1)
 2 reports 285 (10.4) 148 (9.3)
 3 reports 46 (1.7) 15 (0.9)
 4 reports 14 (0.5) Suppressed
 ≥ 5 reports 6 (0.2) Suppressed
Mean patient age (SD) 67.0 (19.5) 69.1 (18.5)
Median patient age [IQR] 71.0 [55.0, 82.0] 73.0 [59.0, 83.0]
Male sex, n (%) 1360 (49.8) 822 (51.7)

Cell sizes < 5 are suppressed

ADE adverse drug event, IQR interquartile range, SD standard deviation

aSerious ADEs are those with an outcome of fetal defect, permanent disability, hospitalisation, extended hospitalisation, life threatening, or death